London, Ont. – Media are invited to attend Tuesday, February 14 at 5 p.m., as London Health Sciences Foundation announces significant funding for Translational Ovarian Cancer Research at London Health Sciences Centre and Lawson Health Research Institute.
Ovarian Cancer tends to avoid detection until it is in a more advanced stage than many other cancers. This makes it more difficult to treat. The funding to be announced on Tuesday will significantly boost the capacity of London’s researchers in unlocking the mysteries of Ovarian Cancer, building world-wide collaborations with other researchers, and in translating research discoveries into clinical trials for improved and new treatments pioneered in London.
At A Glance
What: Program funding announcement regarding Translational Ovarian Cancer Research at LHSC.
Who: London Health Sciences Foundation, LHSC staff and physicians, and Lawson staff and researchers.
When: Tuesday, February 14 at 5 p.m.
Media are asked to be in place 5 minutes prior to the start of the announcement.
Where: London Regional Cancer Program
Zone A, Level 1 Atrium
London Health Sciences Centre
London Health Sciences Foundation (LHSF) is a Canada Revenue Agency registered charity accredited by both Imagine Canada and the Better Business Bureau, linking our community and health care experts - including physicians, allied professionals, researchers, staff and educators - together in pursuit of medical excellence at London Health Sciences Centre (LHSC) and Lawson Health Research Institute (Lawson). Established to strengthen LHSC’s ability to provide the highest quality health care for patients in Southwestern Ontario and beyond, LHSF offers opportunities to support enhanced patient care, education, healthcare innovation and research. www.lhsf.ca.
For the latest news from London Health Sciences Foundation visit www.lhsf.ca/media
For more information: Alex Peterson, LHSF Public Relations Manager
voice: 519.685.8527 email@example.com